TapImmune Inc. Announces Availability of New Investor Information

VANCOUVER, British Columbia, July 17, 2007 (PRIME NEWSWIRE) -- TapImmune Inc., a biotechnology company specializing in the development of immunotherapeutics for cancer and vaccines for infectious diseases, announced today that it has launched a new corporate website with links to media features on its technologies.

MORE ON THIS TOPIC